Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Can Respir J ; 16(6): e77-80, 2009.
Article in English | MEDLINE | ID: mdl-20011721

ABSTRACT

BACKGROUND: Pulmonary vein stenosis is a rare cause of pulmonary hypertension, with variable onset and presentation. One or more of the four pulmonary veins can be primarily or secondarily affected. A five-month-old girl presented with respiratory distress, lethargy and cyanosis requiring intubation. METHODS: Echocardiography showed right ventricular dilation, a right ventricular systolic pressure of 97 mmHg, decreased ejection fraction and turbulent flow at the left atrium. Cardiac catheterization revealed stenosis of the left-sided pulmonary veins, for which she underwent a Coles procedure. RESULTS: Postoperatively, there was a transient improvement in the patient's pulmonary hypertension but she subsequently deteriorated. Her prognosis was considered bleak, and a decision was made with the family to withdraw care. CONCLUSION: Pulmonary vein stenosis is a rare cause of pulmonary hypertension, and is associated with significant morbidity and mortality. Surgical intervention may be of benefit in selected cases. It stands to reason that any treatment will have the best chance of success if completed before the pulmonary hypertension becomes fixed. Early diagnosis depends on a high index of clinical suspicion.


Subject(s)
Hypertension, Pulmonary/etiology , Pulmonary Veins/diagnostic imaging , Pulmonary Veins/pathology , Cardiac Catheterization , Constriction, Pathologic/complications , Female , Humans , Infant , Treatment Outcome , Ultrasonography
2.
Pediatr Pulmonol ; 41(9): 839-43, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16850448

ABSTRACT

Both throat swabs and nasopharyngeal suction (NPS) specimens are used for microbiological assessment in non-sputum-producing patients with cystic fibrosis (CF), but studies comparing their diagnostic yield are lacking. We, therefore, conducted a prospective study in young CF patients, in which both techniques were performed in random order. Forty-seven consecutive CF children aged 6 months to 10 years were studied during routine visits to the clinic. CF relevant pathogens were found in the majority of patients with no significant differences in the rate of positive cultures for Staphylococcus aureus, Haemophilus influenzae, or Pseudomonas aeruginosa. A statistically significant difference was observed in the rate of detection of other organisms with only 9/47 (19%) of throat swab specimens and 27/47 (57%) of NPS specimens being positive (P = 0.0004). This included 12 positive cultures for Streptococcus pneumoniae and 11 cultures that were positive for Moraxella catarrhalis, both of which are frequent colonizers of the upper airway. Therefore, the most common bacterial pathogens affecting the CF lung appear to be detected in similar frequency by throat swab as by nasopharyngeal suction. There is evidence that nasopharyngeal suction yields more specimens of Streptococcus pneumoniae and Moraxella catarrhalis, which may reflect upper airway colonization rather than lower airway infection. We conclude that nasopharyngeal suction is not routinely warranted as there is no benefit over throat swab in detection of CF pathogens in infants and young children with CF.


Subject(s)
Bacteria/isolation & purification , Cystic Fibrosis/microbiology , Nasopharynx/microbiology , Pharynx/microbiology , Child , Child, Preschool , Humans , Infant , Prospective Studies , Suction
3.
Am J Respir Cell Mol Biol ; 22(4): 451-9, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10745026

ABSTRACT

To investigate molecular mechanisms of lung organogenesis, we used representational difference analysis to search for glucocorticoid-inducible genes in developing lung in a fetal rat model. Messenger RNA prepared from fetal and adult rat lung was used to prepare "representative amplicons." Adult-lung complementary DNA (cDNA) amplicons were used as "driver" in successive rounds of subtractive hybridization/amplification to isolate target fetal lung-specific cDNAs. A single clone, which was conserved and had near-perfect homology to eight human/rodent expressed sequence tags, was used as template for 5' and 3' rapid amplification of cDNA ends and SPICE (system for polymerase chain reaction amplification of cDNA ends) reactions to obtain the 3.6-kb cDNA, LGL2 (Genbank, AF 110195) encoding a deduced polypeptide (lgl2) of 963 amino acids. Northern analysis confirmed that LGL2 is differentially expressed in fetal lung (maximal during the pseudoglandular stage, gestational Days 14 to 16), induced by glucocorticoid, and enriched in epithelium relative to the mesenchyme. LGL2 was also detected in human fetal lung at gestational Week 16 as well as in human and rat fetal brain, heart, intestine, and kidney. We mapped LGL2 to chromosome 1p33-34.2. Comparison with sequences in the genome database identified lgl2 as a member of the karyopherin-beta family of nuclear import proteins, with greatest homology to transportin SR. Maximal expression of LGL2 in the pseudoglandular stage of development is coordinate with that of key transcription factors that regulate prominent signal transduction pathways in fetal lung organogenesis. We propose a role for lgl2 in nuclear import of transcription factors that regulate signal transduction during fetal lung development.


Subject(s)
Fetal Proteins/biosynthesis , Gene Expression Regulation, Developmental/drug effects , Hydrocortisone/pharmacology , Lung/embryology , Nuclear Proteins/biosynthesis , Amino Acid Sequence , Animals , Base Sequence , Cells, Cultured , Chromosome Mapping , Chromosomes, Human, Pair 1/genetics , DNA, Complementary/genetics , Escherichia coli , Expressed Sequence Tags , Fetal Proteins/chemistry , Fetal Proteins/genetics , Fetal Proteins/isolation & purification , Fibroblasts/drug effects , Fibroblasts/metabolism , Gestational Age , Humans , In Situ Hybridization, Fluorescence , Lung/metabolism , Models, Molecular , Molecular Sequence Data , Multigene Family , Nuclear Proteins/chemistry , Nuclear Proteins/genetics , Nuclear Proteins/isolation & purification , Protein Conformation , RNA, Messenger/genetics , RNA, Messenger/isolation & purification , Rats , Rats, Wistar , Recombinant Fusion Proteins/biosynthesis , Sequence Alignment , Sequence Homology, Amino Acid , Sequence Homology, Nucleic Acid , Signal Transduction , Species Specificity , Subtraction Technique , beta Karyopherins
4.
Am J Physiol ; 276(6): L1027-36, 1999 06.
Article in English | MEDLINE | ID: mdl-10362728

ABSTRACT

We used differential display-PCR (DD-PCR) to identify glucocorticoid-inducible genes that regulate lung development in late gestation. DD-PCR, a method to screen for differentially expressed genes, is based on a comparison of mRNAs isolated from a subset of two or more cell populations by analysis of RT-PCR products on DNA-sequencing gels. We isolated cDNA probes representing mRNAs expressed in primary cultures of rat lung fibroblasts, but not in epithelial cells, on fetal day 20. A day 20 glucocorticoid-treated fibroblast cDNA library was screened with a single probe to isolate the 3.1-kb cDNA late-gestation lung 1 (LGL1; GenBank accession no. AF109674) encoding a deduced polypeptide of 188 amino acids. Northern analysis confirmed that LGL1 is expressed in human, rat, and mouse fetal lungs, induced by glucocorticoid, developmentally regulated in fibroblasts but not detectable in epithelium. In situ hybridization confirmed LGL1 expression in the mesenchyme, but not in the epithelium, of fetal rat lung, kidney, and gut. The predicted LGL1 gene product (lgl1) showed 81% homology to P25TI, a polypeptide trypsin inhibitor recently identified in human glioblastoma and neuroblastoma cells but not detected in normal human tissues. Both lgl1 and P25TI belong to the CRISP family of cysteine-rich extracellular proteins. Trypsin is produced by both normal bronchial epithelial and lung adenocarcinoma cells. Although additional studies will be necessary to clearly establish a functional role for lgl1, we propose that lgl1 has a role in normal lung development that is likely to be via regulation of extracellular matrix degradation.


Subject(s)
Lung/embryology , Mesoderm/physiology , Neoplasm Proteins/genetics , Proteins/genetics , Sequence Homology, Amino Acid , Trypsin Inhibitors/genetics , Amino Acid Sequence/genetics , Animals , Base Sequence/genetics , Fetus/cytology , Fetus/physiology , Fibroblasts/metabolism , Gene Expression/physiology , Gene Expression Regulation, Developmental/drug effects , Gene Expression Regulation, Developmental/physiology , Glucocorticoids/pharmacology , Lung/cytology , Mesoderm/cytology , Molecular Sequence Data , Rats/embryology , Rats, Wistar
5.
Am J Physiol ; 275(1): L103-9, 1998 07.
Article in English | MEDLINE | ID: mdl-9688941

ABSTRACT

Pulmonary glucocorticoid receptor (GR) is essential to timely preparation for the onset of breathing air at birth. We have previously used primary culture of late-gestation fetal rat lung cells to demonstrate differential regulation of GR by glucocorticoid depending on cell type. In this study, we hypothesized that the action of glucocorticoid on GR mRNA expression and protein elaboration in lung cells might be modulated by interactions present in vivo but not in primary culture. Given that male sex hormone (androgen) has an inhibitory effect on antenatal lung development, we also postulated that androgen would decrease antenatal lung GR. We report that antenatal maternal injection of the glucocorticoid dexamethasone (1 mg/kg) enhanced fetal lung cellular levels of GR mRNA and protein as assessed by in situ hybridization and immunocytochemistry (ICC), respectively. ICC was performed using polyclonal rabbit anti-human antibody that reacts with rat GR whether bound to ligand or not and does not interfere with GR binding to DNA. Levels of GR mRNA and protein were enhanced in cells throughout all areas of the lung tissue, suggesting that interactions occurring in intact tissue may override the previously reported direct inhibition by glucocorticoid of GR protein elaboration in isolated fetal rat lung epithelial cells. Furthermore, antenatal administration of the androgen 5alpha-dihydrotestosterone (0.2 mg/kg) reduced tissue levels of GR mRNA and protein, consistent with androgenic inhibition of antenatal lung development by decreasing GR. We conclude that glucocorticoids and androgens exert opposite effects on fetal lung GR.


Subject(s)
Dexamethasone/pharmacology , Dihydrotestosterone/pharmacology , Lung/embryology , Protein Biosynthesis/drug effects , Receptors, Glucocorticoid/biosynthesis , Transcription, Genetic/drug effects , Animals , Cells, Cultured , Female , Fetus , Gestational Age , Glucocorticoids/pharmacology , Humans , Lung/drug effects , Lung/metabolism , Male , Pregnancy , RNA, Messenger/biosynthesis , Rabbits , Rats , Rats, Wistar
6.
Am J Physiol ; 274(2): C379-86, 1998 02.
Article in English | MEDLINE | ID: mdl-9486127

ABSTRACT

The epithelial Na channel (ENaC) plays a critical role in the active reabsorption of alveolar fluid at the time of birth or during pulmonary edema. Although rat (r) ENaC is regulated by glucocorticoids during fetal development, there are no data regarding the influence of gender hormones on ENaC expression or function. We report higher levels of mRNAs encoding the alpha-rENaC subunit or the cystic fibrosis transmembrane conductance regulator (CFTR) in the lungs of nonpregnant adult female relative to adult male Wistar rats. Combined, but not separate, administration of progesterone and 17 beta-estradiol increased mRNA levels encoding alpha-rENaC, gamma-rENaC, and CFTR within 24 h. We also found a dose-dependent increase in rENaC functional activity (as assessed by the amiloride-sensitive short-circuit current across primary monolayer cultures of alveolar epithelial cells mounted in Ussing chambers) after a 5-day incubation of cells in medium containing progesterone and 17 beta-estradiol. These findings suggest a gender-dependent influence on the lung's ability to recover from pulmonary edema and on the degree of airway fluid hydration in cystic fibrosis.


Subject(s)
Estrogens/physiology , Lung/physiology , RNA, Messenger/metabolism , Sodium Channels/physiology , Animals , Cells, Cultured , Cystic Fibrosis Transmembrane Conductance Regulator/biosynthesis , Epithelial Sodium Channels , Estradiol/pharmacology , Female , Lung/drug effects , Male , Progesterone/pharmacology , Rats , Rats, Wistar , Sex Characteristics , Sodium Channels/drug effects , Sodium Channels/genetics
7.
Am J Physiol ; 272(5 Pt 1): L844-51, 1997 May.
Article in English | MEDLINE | ID: mdl-9176247

ABSTRACT

Sex hormones modulate two normal processes of late-gestation mammalian lung development: the onset of augmented production of surfactant phospholipids and the loss of mesenchymal cells. As prenatal lung development advances, epithelial chloride secretory pathways diminish as opposing sodium absorptive pathways increase in expression. We hypothesized that sex hormones may influence both the gene expression and functional activity of the chloride channel known as the cystic fibrosis transmembrane conductance regulator (CFTR) in fetal lung epithelium. We report here that sex hormones exert opposite effects on CFTR. Androgen increases and estrogen decreases CFTR functional activity [as assessed by CFTR antisense (but not sense) oligodeoxynucleotide-sensitive adenosine 3',5'-cyclic monophosphate-stimulated cell volume reduction or by glibenclamide-sensitive, amiloride-insensitive transepithelial electrical potential] in primary cultures of fetal rat lung epithelial cells. No alterations in CFTR mRNA levels measured by quantitative polymerase chain reaction amplification of reverse transcripts) accompanied either the changes in functional activity induced by sex hormones or the changes observed during normal development, suggesting that sex hormone modulation of CFTR in antenatal lung occurs at a posttranscriptional level. Our data are consistent with the hypothesis that both androgen and estrogen contribute to the male disadvantage with respect to fetal lung functional development.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Fetus/metabolism , Gonadal Steroid Hormones/physiology , Lung/embryology , Animals , Cells, Cultured , Colforsin/pharmacology , Cystic Fibrosis Transmembrane Conductance Regulator/antagonists & inhibitors , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Dihydrotestosterone/pharmacology , Embryonic and Fetal Development , Epithelial Cells , Epithelium/embryology , Fetus/cytology , Gestational Age , Lung/cytology , RNA, Messenger/metabolism , Rats/embryology , Rats, Wistar , Tetradecanoylphorbol Acetate/pharmacology
8.
Am J Physiol ; 271(5 Pt 1): G747-54, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8944687

ABSTRACT

The cystic fibrosis (CF), gene product, CF transmembrane conductance regulator (CFTR), is responsible for adenosine 3',5'-cyclic monophosphate (cAMP)-activated Cl- transport in epithelial cells, and mutant CFTR accounts for the pathology in the CF pancreas. We have previously shown that both isolated rabbit pancreatic acini and the human pancreatic duct cell line PANC-1 possess a cAMP-activated Cl- conductance identified as CFTR. We report here that preincubation in either of the female hormones progesterone or beta-estradiol inhibits activation by cAMP, but not by Ca2+ ionophore, of PANC-1 cell volume reduction under isotonic conditions. cAMP-activated cell volume reduction is sensitive to antisense, but not sense, CFTR oligodeoxynucleotide. Furthermore, progesterone inhibits cAMP-activated Cl- efflux from rabbit acinar cells. Moreover preincubation with progesterone, but not beta-estradiol, reduces CFTR mRNA and protein levels as measured using polymerase chain reaction amplification of reverse-transcribed acinar RNA and Western blots of protein from acinar membranes. We conclude that female hormones inhibit CFTR functional activity in pancreatic epithelial cells by different mechanisms.


Subject(s)
Chlorides/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator/biosynthesis , Estradiol/pharmacology , Oligonucleotides, Antisense/pharmacology , Pancreas/metabolism , Progesterone/pharmacology , Transcription, Genetic , 8-Bromo Cyclic Adenosine Monophosphate/pharmacology , Animals , Base Sequence , Calcimycin/pharmacology , Calcium/metabolism , Cell Line , Cells, Cultured , Cyclic AMP/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator/antagonists & inhibitors , DNA Primers , Epithelial Cells , Epithelium/drug effects , Epithelium/metabolism , Female , Humans , Male , Oligodeoxyribonucleotides/pharmacology , Pancreas/cytology , Polymerase Chain Reaction , RNA, Messenger/biosynthesis , Rabbits
9.
Pediatr Res ; 38(4): 506-12, 1995 Oct.
Article in English | MEDLINE | ID: mdl-8559601

ABSTRACT

The glucocorticoid receptor (GR) mediates glucocorticoid stimulation of surfactant production by fetal mammalian lung. In many other tissues, glucorticoids decrease expression of GR, thereby reducing responsiveness to these hormones. We therefore determined whether there is a similar effect of exogenous glucocorticoids on GR in fetal rat whole lung, and in the principal cell types involved in the stimulation of surfactant, the fibroblasts and the epithelial cells. The ontogeny of GR in late gestation lung differed between the two cell types, with maximal levels occurring in fibroblasts on gestational d 19, and on d 20 in epithelial cells. Administration of dexamethasone (1 mg/kg) to the mother on gestational d 18 or 19 (term = 22 d) increased specific GR binding activity in whole lung 24 h later. Furthermore, in vitro, incubation of cultured fibroblasts of gestational d 20 with 10(-7) M cortisol increased GR immunoreactive protein and binding activity in a dose- and time-dependent manner, without affecting cellular levels of GR mRNA. However, identical treatment of d 20 distal airway epithelial cells was followed by decreased GR protein without significant change in cellular GR mRNA. Surfactant protein-A protein levels, taken as assessments of lung maturation, were increased in response to the same treatment. Our findings suggest that hormonal regulation of GR in fetal lung cells occurs at a posttranscriptional level, and is cell-specific. In the context of substantial increases in circulating glucocorticoid concentrations during late gestation, these findings may be of physiologic importance to the biochemical maturation of the antenatal lung.


Subject(s)
Fetus/metabolism , Lung/metabolism , Receptors, Glucocorticoid/genetics , Animals , Cells, Cultured , Gene Expression Regulation, Developmental , Gestational Age , Hydrocortisone/pharmacology , Ligands , Lung/drug effects , Lung/embryology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar , Receptors, Glucocorticoid/drug effects , Receptors, Glucocorticoid/metabolism
10.
Pediatr Res ; 35(1): 45-9, 1994 Jan.
Article in English | MEDLINE | ID: mdl-7510872

ABSTRACT

Fluid secretion from the pulmonary epithelium may play a significant role in determining intrauterine lung development. We used suspensions of distal pulmonary epithelial cells isolated from rat fetuses to assess a shift in secretory mechanisms occurring in the lung of this species during late gestation. The impact of cAMP on distal airway epithelial cells isolated from d 18 to d 21 rat fetuses was evaluated with measurements of cell volume and 36Cl efflux rates. At d 18, 8-Br-cAMP stimulated a volume reduction measured by electronic cell sizing that was prevented by the Cl- channel blocker anthracene-9-carboxylate (A-9C) and reflected in an increased rate of A-9C sensitive 36Cl efflux. Because the cystic fibrosis transmembrane conductance regulator (CFTR) is thought to be a cAMP-regulated Cl- channel, we measured the effect of prior cell incubation with oligodeoxynucleotides antisense to the transcription site of the human CFTR gene on these events. We found that in antisense oligomer-treated cells, but not in sense oligomer-treated controls, volume and 36Cl efflux responses to 8-Br-cAMP were prevented in d 18 cells. In d 21 cells, 8-Br-cAMP did not stimulate volume reduction but the calcium ionophore A23187 did elicit cell volume reduction in cells suspended in an isotonic Ca(2+)-containing medium that was prevented by A-9C. This response to the ionophore was not found in the d 18 cells, and incubation with the antisense CFTR oligomer had no effect on the ionophore-induced responses in d 21 cells.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Cystic Fibrosis/metabolism , Membrane Proteins/metabolism , Pulmonary Alveoli/metabolism , 8-Bromo Cyclic Adenosine Monophosphate/pharmacology , Animals , Base Sequence , Calcimycin/pharmacology , Cell Size/drug effects , Chloride Channels/drug effects , Chloride Channels/metabolism , Chlorides/metabolism , Cystic Fibrosis/genetics , Cystic Fibrosis Transmembrane Conductance Regulator , Epithelial Cells , Epithelium/metabolism , Fetus/cytology , Fetus/metabolism , Gene Expression , Gestational Age , In Vitro Techniques , Membrane Proteins/genetics , Molecular Sequence Data , Oligonucleotides, Antisense/genetics , Oligonucleotides, Antisense/pharmacology , Pulmonary Alveoli/cytology , Rats
11.
Am J Respir Cell Mol Biol ; 5(4): 371-6, 1991 Oct.
Article in English | MEDLINE | ID: mdl-1910822

ABSTRACT

The autocrine, paracrine, or systemic growth factors responsible for fetal lung cell growth are not completely defined. The progression-type insulin-like growth factors and epidermal growth factor, or transforming growth factor-alpha acting through the epidermal growth factor receptor, appear to act on the developing lung epithelium. The competence factors that facilitate the actions of progression factors during lung growth are unknown. Fetal rat lung cells in vitro synthesize a platelet-derived growth factor (PDGF)-like polypeptide, which we have hypothesized may play a paracrine role in normal lung development. Slot blot and Northern blot analyses of fetal rat lung mRNA have been used to determine if there is a relationship between expression of message for PDGF-A or PDGF-B chains, or their cognate receptors, and periods of maximal growth during late fetal rat lung development. Whole lung mRNA was extracted on 18, 19, 20, 21, and 22 days of gestation (term = 22 days). The peak of DNA synthesis, as assessed by expression of message for DNA polymerase alpha, histone 3, and the proto-oncogenes c-fos and c-myc, which are stimulated by binding of growth factors including PDGF, occurred during the canalicular stage of lung development on days 19 and 20 of gestation. Expression of message for PDGF-A and PDGF-B chains was low during the pseudoglandular stage on day 18, peaked during the canalicular stage on days 19 and 20, then fell again during the saccular stage at days 21 and 22 of gestation.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
DNA Polymerase II/genetics , Genes, fos , Genes, myc , Histones/genetics , Lung/metabolism , Platelet-Derived Growth Factor/genetics , Animals , Blotting, Northern , DNA/biosynthesis , Female , Lung/cytology , Lung/embryology , Pregnancy , RNA, Messenger/metabolism , Rats
12.
Chest ; 97(6): 1322-6, 1990 Jun.
Article in English | MEDLINE | ID: mdl-2347216

ABSTRACT

We studied the long-term outcome after BAE for life-threatening hemoptysis in patients with CF. Data from pulmonary function tests were available for 18 of the 25 patients followed. A case-control comparison revealed that these 18 patients died sooner than hemoptysis-free patients with CF matched for age, sex, and pulmonary function (p less than 0.02), with the excess mortality occurring within the first three months after BAE. Of all 25 patients followed, six died of cardiorespiratory failure within three months of BAE; in two of them, hemoptysis was a contributing cause of death. The 19 patients who lived more than three months after BAE had a mean survival after embolization of 3.5 years (five were still alive at the end of the study). Most patients experienced long intervals (greater than 1 year) free of major hemoptysis. Extended follow-up (mean, 35 months) revealed a higher incidence of recurrent severe bleeding than previously reported for 13 of these patients followed a mean of 11 months. Repeat BAE for severe recurrence was performed successfully in eight of nine patients, without complication.


Subject(s)
Bronchial Arteries , Cystic Fibrosis/complications , Embolization, Therapeutic , Hemoptysis/therapy , Adult , Case-Control Studies , Cystic Fibrosis/mortality , Female , Follow-Up Studies , Gelatin Sponge, Absorbable , Hemoptysis/etiology , Hemoptysis/mortality , Humans , Male , Time Factors
13.
Exp Cell Res ; 188(1): 89-96, 1990 May.
Article in English | MEDLINE | ID: mdl-2328780

ABSTRACT

The male fetal lung begins to synthesize surfactant later in gestation than the female. This delay appears to be caused by androgens. We hypothesized that male fetal lung differentiation is delayed as a consequence of an extended phase of growth which is elicited by androgens. We observed that in vivo fetal lung protein synthesis relative to DNA synthesis peaked earlier in gestation in the female fetal lung and that this event was synchronous with the onset of differentiation. Pregnant rats were treated with dihydrotestosterone (DHT) during pregnancy, and fetal lung growth parameters were measured. Lung wet weight, dry weight, and DNA and protein concentrations were significantly elevated by DHT treatment. Type II cells and fibroblasts were isolated from lungs of DHT-treated fetuses. The number of total cells recovered was increased by 30%; the number of type II cells recovered was increased by 87%; and the number of fibroblasts recovered was increased by 42%. The type II cells which were recovered exhibited increased incorporation of [3H]thymidine into DNA and a reduced ratio of radiolabeled protein to radiolabeled DNA compared to that of cells from control lungs. Further studies were done in vitro with fibroblasts and type II cells isolated from untreated fetal rat lungs. Treatment of the fibroblasts with DHT during culture caused an increase in thymidine incorporation into DNA. This effect was not blocked by simultaneous treatment with cortisol, which normally causes reduced DNA synthesis and induces fibroblast differentiation. Treatment of the type II cells with DHT in culture caused a dose-dependent increase in cell number but a decrease in synthesis of disaturated phosphatidylcholine. These studies provide more direct evidence of the interrelationships between the control of growth and the control of differentiation in the fetal lung. DHT, a signal which delays the onset of expression of differentiation, also induces growth. We conclude that the controls of growth and of differentiation of the fetal lung are reciprocally linked.


Subject(s)
Fetus/cytology , Lung/embryology , Androgens/metabolism , Androgens/pharmacology , Animals , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cell Division/drug effects , Cell Division/physiology , DNA/biosynthesis , Fetus/metabolism , Fetus/physiology , Lung/metabolism , Lung/ultrastructure , Mice , Protein Biosynthesis , Pulmonary Surfactants/biosynthesis , Receptors, Androgen/metabolism , Receptors, Androgen/pharmacology
14.
Radiology ; 171(3): 811-4, 1989 Jun.
Article in English | MEDLINE | ID: mdl-2717757

ABSTRACT

Chest radiographs were compared for three groups of children 8-9 years old: 23 survivors of bronchopulmonary dysplasia (BPD), 33 survivors of hyaline membrane disease without BPD, and 35 survivors of premature birth without neonatal respiratory problems. Only four children in the second group and three in the third had abnormal lungs. Linear shadows, apparently representing strands of fibrosis or deep pleural fissuring, were seen more frequently (15 of 23) in the BPD group than in the others (P less than .0001). Seventeen children in the BPD group had definite pulmonary abnormalities, none of them severe. The anteroposterior dimension of the chest in survivors of BPD tended to be decreased (P less than .001 vs that of reported control subjects).


Subject(s)
Aging , Bronchopulmonary Dysplasia/diagnostic imaging , Aging/physiology , Bronchopulmonary Dysplasia/physiopathology , Bronchospirometry , Follow-Up Studies , Humans , Infant, Newborn , Radiography
15.
J Clin Endocrinol Metab ; 62(2): 445-9, 1986 Feb.
Article in English | MEDLINE | ID: mdl-3941166

ABSTRACT

We report a patient with neonatal severe primary hyperparathyroidism whose parathyroid cells were markedly refractory to regulation by calcium in vitro. He showed life-threatening hypercalcemia (4.8-5.2 mM vs. normal of 2.1-2.7 mM). A sibling had been treated previously for an identical disorder. At age 6.5 months, four hyperplastic parathyroid glands were removed, and portions of one were immediately grafted into the forearm. Serum calcium again became elevated post-operatively and then fall to the normal range after excision of grafted parathyroid tissue. Dispersed parathyroid cells from the first operation showed no suppression of PTH secretion by 2 mM calcium; however, there was normal maximal suppressibility at 4 mM calcium with half-maximal suppression at 2.53 mM (the calcium set point). This contrasts with much lower set points previously established for suppressible cells from normal (1.02 +/- 0.10 mM, mean +/- 1 SD), from primary hyperplastic (1.10 +/- 0.14 mM), or from adenomatous (1.26 +/- 0.14 mM) parathyroid glands. The strikingly high set point may not be unique because a small number of glands previously classified as nonsuppressible (by the criterion of failing to suppress below 50% maximum at calcium concentration up to 2-3 mM) might have shown similarly high set points if tested at higher calcium concentrations. We conclude that an unusual abnormality of PTH secretory control accounts, in large part, for both the marked hypercalcemia and for its refractoriness to surgical treatment in this patient.


Subject(s)
Hyperparathyroidism/physiopathology , Parathyroid Glands/metabolism , Parathyroid Hormone/metabolism , Calcium/physiology , Humans , Hypercalcemia/physiopathology , Infant, Newborn , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...